These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10817788)

  • 1. Secondary genetic factors in cystic fibrosis lung disease.
    Mahadeva R; Lomas DA
    Thorax; 2000 Jun; 55(6):446. PubMed ID: 10817788
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic modifiers of lung disease in cystic fibrosis.
    Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
    N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathophysiologic mechanisms of cystic fibrosis lung disease.
    Soferman R
    Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and pulmonary medicine. 1. The genetics of cystic fibrosis lung disease.
    Davidson DJ; Porteous DJ
    Thorax; 1998 May; 53(5):389-97. PubMed ID: 9708232
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic fibrosis: a further case of an asymptomatic compound heterozygote.
    White SM; Lucassen A; Norbury G
    Am J Med Genet; 2001 Nov; 103(4):342-3. PubMed ID: 11746017
    [No Abstract]   [Full Text] [Related]  

  • 8. Late CF caused by homozygous IVS8-5T CFTR polymorphism.
    Cottin V; Thibout Y; Bey-Omar F; Durieu I; Laoust L; Morel Y; Cordier JF
    Thorax; 2005 Nov; 60(11):974-5. PubMed ID: 16263954
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic benefit of ivacaftor in late cystic fibrosis caused by homozygous IVS8-5T CFTR polymorphism.
    Magne F; Durupt S; Nove-Josserand R; Bey-Omar F; Laoust L; Cottin V; Durieu I; Reynaud Q
    J Cyst Fibros; 2017 Jan; 16(1):89-90. PubMed ID: 27810230
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystic fibrosis: the conductance regulator, ceramides, and possible treatments.
    Luft FC
    J Mol Med (Berl); 2017 Oct; 95(10):1017-1019. PubMed ID: 28831504
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.
    Melotti P; Mafficini A; Lebecque P; Ortombina M; Leal T; Pintani E; Pepermans X; Sorio C; Assael BM
    PLoS One; 2014; 9(12):e114274. PubMed ID: 25503271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis mutation I1234V in a Qatari lady.
    Wahab AA
    J Trop Pediatr; 2003 Feb; 49(1):54-5. PubMed ID: 12630722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interference of P1290 P polymorphism (4002 A--> G) in molecular diagnosis of mucoviscidosis using the cystic fibrosis assay: an example of a diagnostic trap].
    Bienvenu T; Bousquet S; Souville I; Beldjord C
    Ann Biol Clin (Paris); 1999; 57(6):741-2. PubMed ID: 10572229
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of more than 91% cystic fibrosis mutations in a sample of the population from Reunion Island and identification of two novel mutations (A309G, S1255L) and one novel polymorphism (L49L).
    Cartault F; Steffann J; Vidaud D; Bousquet S; Lesure F; Renouil M; McDonell N; Feingold J; Beldjord C; Bienvenu T
    Clin Genet; 1998 Nov; 54(5):437-9. PubMed ID: 9842999
    [No Abstract]   [Full Text] [Related]  

  • 15. The genetics of cystic fibrosis.
    Pignatti PF
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):603-5. PubMed ID: 10063328
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies for identifying modifier genes in cystic fibrosis.
    Boyle MP
    Proc Am Thorac Soc; 2007 Jan; 4(1):52-7. PubMed ID: 17202292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mild variant of cystic fibrosis.
    Alton EW
    Thorax; 1996 Aug; 51 Suppl 2(Suppl 2):S51-4. PubMed ID: 8869353
    [No Abstract]   [Full Text] [Related]  

  • 18. Modifier genes in cystic fibrosis.
    Davies JC; Griesenbach U; Alton E
    Pediatr Pulmonol; 2005 May; 39(5):383-91. PubMed ID: 15765543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of gene therapy for cystic fibrosis lung disease.
    Boucher RC
    J Clin Invest; 1999 Feb; 103(4):441-5. PubMed ID: 10021450
    [No Abstract]   [Full Text] [Related]  

  • 20. Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.
    Velard F; Delion M; Le Henaff C; Guillaume C; Gangloff S; Jacquot J; Tabary O; Touqui L; Barthes F; Sermet-Gaudelus I
    Am J Respir Crit Care Med; 2014 Mar; 189(6):746-8. PubMed ID: 24628315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.